Treatment for Prostate Cancer

MemorialCare Saddleback Medical Center, Laguna Hills, CA
Prostate Cancer

Study Summary

This trial is testing the effectiveness of a new type of radiation therapy called TrueBeam in treating prostate cancer. The hope is that this new therapy will be more effective in treating the tumor while minimizing injury to nearby healthy tissue.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 5 years

5 years
Local control

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

0 Treatment Group

167 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

Linda Chan, MDLead Sponsor

Eligibility Criteria

Age Any Age · Male Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there any available vacancies for this research endeavor?

"Data accessible on reports that this trial is in its recruitment stage, with the first post being made on June 5th 2018 and the last update taking place November 3rd 2022." - Anonymous Online Contributor

Unverified Answer

What is the current cohort size of this research study?

"Affirmative.'s data suggests that this research endeavor, which was initially posted on June 5th 2018, is currently soliciting participants. Approximately 167 individuals must be recruited from a single center." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.